Immunohistochemistry (IHC) staining showed that the right breast cancer was positive for estrogen receptor (ER), progesterone receptor (PR) and p53, but negative for human epidermal growth factor receptor-2 (HER-2). This evidence concerns the gene ESR1 and breast carcinoma.